Squalene Selectively Protects Mouse Bone Marrow Progenitors Against Cisplatin and Carboplatin-Induced Cytotoxicity In Vivo Without Protecting Tumor Growth
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Squalene, an isoprenoid antioxidant is a potential cytoprotective agent against chemotherapy-induced toxicity. We have previously published that squalene protects light-density bone marrow cells against cis-diamminedichloroplatinum( II) (cisplatin)-induced toxicity without protecting tumor cells in vitro. Here, we developed an in vivo mouse model of cisplatin and cis-diammine (cyclobutane-1,1-dicarboxylato) platinum(II) (carboplatin)-induced toxicity to further investigate squalene-mediated LD-BM cytoprotection including the molecular mechanism behind selective cytoprotection. We found that squalene significantly reduced the body weight loss of cisplatin and carboplatin-treated mice. Light-density bone marrow cells from squalene-treated mice exhibited improved formation of hematopoietic colonies (colony-forming unit-granulocyte macrophage). Furthermore, squalene also protected mesenchymal stem cell colonies (colony-forming unit-fibroblast) from cisplatin and carboplatin-induced toxicity. Squalene-induced protection was associated with decreased reactive oxygen species and increased levels of glutathione and glutathione peroxidase/glutathione-S-transferase. Importantly, squalene did not protect neuroblastoma, small cell carcinoma, or medulloblastoma xenografts against cisplatin-induced toxicity. These results suggest that squalene is a potential candidate for future development as a cytoprotective agent against chemotherapeutic toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro
Imlay, J. A., Chin, S. M., & Linn, S. (1988) · Science · doi:10.1126/science.2834821 · Cited by 1,555 · cited 1×
“[74] Imlay JA, Chin SM, and Linn S (1988).”
BackgroundBrusselmans, K., Timmermans, L., Van de Sande, T., Van Veldhoven, P. P., Guan, G., Shechter, I., Claessens, F., Verhoeven, G., & Swinnen, J. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611763200 · Cited by 116 · cited 2×
“[87] Brusselmans K, Timmermans L, Van de Sande T, Van Veldhoven PP, Guan G,”
Background
Cited by
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
“Squalene reduces ROS levels and upregulates glutathione levels among other detoxifying enzymes, with no effect on tumor cells as in neuroblastoma, small cell carcinoma and medulloblastoma xenografts [55].”
BackgroundSelf-citationSqualene: A natural triterpene for use in disease management and therapy
Reddy, L. H., & Couvreur, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.005 · Cited by 397
Squalene – biochemistry, molecular biology, process biotechnology, and applications
Spanova, M., & Daum, G. (2011) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201100203 · Cited by 268
Yang, K., Yu, G., Yang, Z., Yue, L., Zhang, X., Sun, C., Wei, J., Rao, L., Chen, X., & Wang, R. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202103721 · Cited by 255
Breen, D. M., Kim, H., Bennett, D., Calle, R. A., Collins, S., Esquejo, R. M., He, T., Joaquim, S., Joyce, A., Lambert, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.023 · Cited by 185
“The dose of cisplatin was chosen in an attempt to balance literature reports of effective anti-tumor activity while avoiding severe weight loss due to overt toxicity (Aston et al., 2017; Das et al., 2008).”
BackgroundGohil, N., Bhattacharjee, G., Khambhati, K., Braddick, D., & Singh, V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00050 · Cited by 121
“In the subsequent study, Das et al. (2008) presented the experimental evidence of squalene’s role in protecting healthy bone marrow cells while having no obvious effect on the neuroblastoma cells.”
Das, B., Pal, B., Bhuyan, R., Li, H., Sarma, A., Gayan, S., Talukdar, J., Sandhya, S., Bhuyan, S., Gogoi, G., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2847 · Cited by 92
Self-citationNarayan Bhilwade, H., Tatewaki, N., Nishida, H., & Konishi, T. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110793262088 · Cited by 84
“In bone marrow cells of cisplatin treated mice [49]”
BackgroundInfluentialHeylman, C., Sobrino, A., Shirure, V. S., Hughes, C. C., & George, S. C. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214525295 · Cited by 53
“Toxicity of pharmacological agents toward HSCs is a major problem for many therapeutic strategies, including cancer chemotherapy.(64,65) Many antineoplastic drugs directly target the machinery of cell proliferation and thus also target HSC, which can be either quiescent, undergoing self-renewal, or differentiating int…”
Background
Metadata
- Authors
- Das, B., Antoon, R., Tsuchida, R., Lotfi, S., Morozova, O., Farhat, W., Malkin, D., Koren, G., Yeger, H., & Baruchel, S.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 10
- Issue
- 10
- Pages
- 1105-IN4
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W1245741737
- Cited by
- 90
- References
- 2
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.